What is a stock summary page? Click here for an overview.
Business Description
Oxford BioDynamics PLC
ISIN : GB00BD5H8572
Description
Oxford BioDynamics PLC is a biotechnology company engaged in developing and commercializing precision clinical diagnostic tests for life-changing diseases. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The tests are based on the company's proprietary 3D genomic biomarker platform, EpiSwitch which enables screening, evaluation, validation, and monitoring of biomarkers. In addition, the company offers, EpiSwitch Explorer Array Kit for 3D genome profiling. It is also developing new tests in the areas of oncology, neurology, inflammation, hepatology, and animal health. Geographically, it derives key revenue from the United States of America.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.49 | |||||
| Equity-to-Asset | 0.36 | |||||
| Debt-to-Equity | 1.32 | |||||
| Debt-to-EBITDA | -0.56 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -7.05 | |||||
| Beneish M-Score | -2.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.6 | |||||
| 3-Year EBITDA Growth Rate | 16.6 | |||||
| 3-Year EPS without NRI Growth Rate | 16.4 | |||||
| 3-Year FCF Growth Rate | 24.3 | |||||
| 3-Year Book Growth Rate | -42.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 0.04 | |||||
| 6-1 Month Momentum % | -93.33 | |||||
| 12-1 Month Momentum % | -90 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.97 | |||||
| Quick Ratio | 1.84 | |||||
| Cash Ratio | 1.1 | |||||
| Days Inventory | 288.91 | |||||
| Days Sales Outstanding | 249.07 | |||||
| Days Payable | 1438.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -49.9 | |||||
| Shareholder Yield % | -103.62 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.44 | |||||
| Operating Margin % | -1886.48 | |||||
| Net Margin % | -1818.71 | |||||
| FCF Margin % | -1702.55 | |||||
| ROE % | -288.33 | |||||
| ROA % | -88.3 | |||||
| ROIC % | -114.75 | |||||
| 3-Year ROIIC % | 253.06 | |||||
| ROC (Joel Greenblatt) % | -184.32 | |||||
| ROCE % | -121.64 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.58 | |||||
| PB Ratio | 0.34 | |||||
| Price-to-Tangible-Book | 0.4 | |||||
| EV-to-EBIT | -1.04 | |||||
| EV-to-EBITDA | -1.19 | |||||
| EV-to-Forward-EBITDA | -1.18 | |||||
| EV-to-Revenue | 19.2 | |||||
| EV-to-Forward-Revenue | 8.07 | |||||
| EV-to-FCF | -1.13 | |||||
| Price-to-GF-Value | 0.01 | |||||
| Earnings Yield (Greenblatt) % | -96.15 | |||||
| FCF Yield % | -115.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:OXBOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oxford BioDynamics PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.825 | ||
| EPS (TTM) ($) | -0.058 | ||
| Beta | -13.64 | ||
| 3-Year Sharpe Ratio | 0.57 | ||
| 3-Year Sortino Ratio | 6.05 | ||
| Volatility % | 127.06 | ||
| 14-Day RSI | 0.04 | ||
| 14-Day ATR ($) | 0.000183 | ||
| 20-Day SMA ($) | 0.0061 | ||
| 12-1 Month Momentum % | -90 | ||
| 52-Week Range ($) | 0.004 - 0.15 | ||
| Shares Outstanding (Mil) | 1,957.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Oxford BioDynamics PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oxford BioDynamics PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Oxford BioDynamics PLC Frequently Asked Questions
What is Oxford BioDynamics PLC(OXBOF)'s stock price today?
The current price of OXBOF is $0.00. The 52 week high of OXBOF is $0.15 and 52 week low is $0.00.
When is next earnings date of Oxford BioDynamics PLC(OXBOF)?
The next earnings date of Oxford BioDynamics PLC(OXBOF) is 2025-06-18 Est..
Does Oxford BioDynamics PLC(OXBOF) pay dividends? If so, how much?
Oxford BioDynamics PLC(OXBOF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers